P-064 - A FIRST-IN-HUMAN, DOSE-ESCALATION, DRUG-INTERACTION, AND FOOD-EFFECT STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF INCB106385, A SELECTIVE ADENOSINE RECEPTOR ANTAGONIST, IN HEALTHY ADULTS.
J. Getsy, A. Barbour, K. Rockich, C. Leonetti-Whalen, B. Yuska, R. McGee, G. Zhou, X. Chen, S. Yeleswaram, N. Punwani; Incyte Corporation, Wilmington, DE, USA.
.png)